Author:
Wang Lei, ,Liu Na,Miao Ning,Zhang Guomin,Wang Fuzhen,Wang Huaqing
Publisher
Chinese Center for Disease Control and Prevention
Reference10 articles.
1. Centers for Disease Control and Prevention. Progress in hepatitis B prevention through universal infant vaccination — China, 1997–2006. MMWR Morb Mortal Wkly Rep 2007;56(18):441-5. https://www.cdc.gov/mmwr/preview/mmwrhtml/mm5618a2.htm.
2. Liu ZQ, Lin CQ, Mao XH, Guo CN, Suo C, Zhu DL, et al. Changing prevalence of chronic hepatitis B virus infection in China between 1973 and 2021: a systematic literature review and meta-analysis of 3740 studies and 231 million people. Gut 2023;72(12):2354 − 63. https://doi.org/10.1136/gutjnl-2023-330691.
3. Orenstein W, Offit P, Edwards KM, Plotkin S. Plotkin’s vaccines. 8th ed. Amsterdam: Elsevier. 2023; p. 404-5. http://dx.doi.org/10.1016/C2019-0-00240-3.
4. Miao N, Zheng H, Sun XJ, Wang FZ, Zhang GM, Yin ZD. Acute hepatitis B — China, 2005−2019. China CDC Wkly 2020;2(30):559 − 63. https://doi.org/10.46234/ccdcw2020.150.
5. Bixler D, Roberts H, Panagiotakopoulos L, Nelson NP, Spradling PR, Teshale EH. Progress and unfinished business: hepatitis B in the United States, 1980-2019. Public Health Rep 2023;333549231175548. http://dx.doi.org/10.1177/00333549231175548.